Literature DB >> 14526209

Changes in HIV-related preventive behavior in the US population: data from national surveys, 1987-2002.

John E Anderson1, John Santelli, Constance Mugalla.   

Abstract

This study estimated 1987-2002 trends in preventive behaviors closely linked to HIV from several large health surveys providing the most recently available data. These behaviors include condom use, dual use of condoms with other contraceptive methods, and HIV testing. Condom use increased throughout the period for adolescents, but there is no evidence of overall increased condom use for adults after the mid-1990s. After 2000, adult condom use with primary partners was low even among those at highest risk. Dual use of condoms with other contraceptive methods was reported by a small and increasing percentage of adolescents and adults. By 2001 a high percentage of US adults reported having been tested at least once, and reproductive-age and pregnant women were tested at a greater rate than others. However, 1 in 4 pregnant women had never been tested for HIV. This review indicates that even after considerable increase in preventive behaviors, it is still possible to identify a relatively large segment of the population that is at risk for transmitting or acquiring HIV. Prevention programs serving high-risk populations need to work toward increasing safe sex practices with main partners and HIV testing among the never-tested, particularly reproductive-age women.

Entities:  

Mesh:

Year:  2003        PMID: 14526209     DOI: 10.1097/00126334-200310010-00010

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  9 in total

1.  Condoms for dual protection: patterns of use with highly effective contraceptive methods.

Authors:  Karen Pazol; Michael R Kramer; Carol J Hogue
Journal:  Public Health Rep       Date:  2010 Mar-Apr       Impact factor: 2.792

2.  HIV testing among U.S. women during prenatal care: findings from the 2002 National Survey of Family Growth.

Authors:  John E Anderson; Stephanie Sansom
Journal:  Matern Child Health J       Date:  2006-09

3.  HIV behavioral surveillance among the U.S. general population.

Authors:  Amy Lansky; Amy Drake; Elizabeth DiNenno; Chung-won Lee
Journal:  Public Health Rep       Date:  2007       Impact factor: 2.792

4.  Trends in prenatal discussion and HIV testing, 1996-2001: Pregnancy Risk Assessment Monitoring System.

Authors:  Amy Lansky; Stephanie L Sansom; Leslie L Harrison; Tonya Stancil
Journal:  Matern Child Health J       Date:  2007-03-06

Review 5.  Contraceptive methods and risk of HIV acquisition or female-to-male transmission.

Authors:  Lisa B Haddad; Chelsea B Polis; Anandi N Sheth; Jennifer Brown; Athena P Kourtis; Caroline King; Rana Chakraborty; Igho Ofotokun
Journal:  Curr HIV/AIDS Rep       Date:  2014-12       Impact factor: 5.071

6.  HIV Testing in Publicly Funded Settings, National Health Interview Survey, 2003-2010.

Authors:  Cheryl Tan; Michelle Van Handel; Christopher Johnson; Patricia Dietz
Journal:  Public Health Rep       Date:  2016 Jan-Feb       Impact factor: 2.792

7.  The relationship of reported HIV risk and history of HIV testing among emergency department patients.

Authors:  Roland C Merchant; Sarah M Freelove; Thomas J Langan; Melissa A Clark; Kenneth H Mayer; George R Seage; Victor G DeGruttola
Journal:  Postgrad Med       Date:  2010-01       Impact factor: 3.840

8.  Multiple method contraception use among African American adolescents in four US cities.

Authors:  Jennifer L Brown; Michael Hennessy; Jessica M Sales; Ralph J DiClemente; Laura F Salazar; Peter A Vanable; Michael P Carey; Daniel Romer; Robert F Valois; Larry K Brown; Bonita Stanton
Journal:  Infect Dis Obstet Gynecol       Date:  2011-07-18

9.  The impact of oral contraceptive initiation on young women's condom use in 3 American cities: missed opportunities for intervention.

Authors:  Chelsea Morroni; Stephen Heartwell; Sharon Edwards; Mimi Zieman; Carolyn Westhoff
Journal:  PLoS One       Date:  2014-07-08       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.